ReviewPublished 12 October 2026A review on advances in chemical compound toxicology predictionAhmed Hagag · Nada A. Elsayed · Ibrahim AbdelbakyFrontiers in Bioinformaticsdoi 10.3389/fbinf.2026.1974935
Original ResearchPublished 12 October 2026Exploring the protective mechanism of Huangqishengmaiyin against anthracycline-induced cardiotoxicity in breast cancer with concomitant gut microbiota modulationYixuan Wang · Yeying Jin · Jiali Han · Mingjia Ding · Haoqing Hou · Miaoyu Mei · Rui YangFrontiers in Cardiovascular Medicinedoi 10.3389/fcvm.2026.1818551
Mini ReviewPublished 12 October 2026Arsenic trioxide-induced cardiotoxicity: insights into the oxidative stress-inflammation positive feedback loop, translational biomarkers and targeted cardioprotective strategies— a narrative reviewHaiyan Wu · Jian Lv · Xiaoyang HuFrontiers in Oncologydoi 10.3389/fonc.2026.1954263
Systematic ReviewPublished 9 October 2026Efficacy of beta-blockers in preventing cardiotoxicity in breast cancer patients receiving anthracyclines: a GRADE-assessed systematic review and meta-analysis with trial sequential analysisVictor M. Samperio · Lorena M. Murrieta Bruciaga · Jesús Antonio Castañeda Martínez · Vanessa Coronado Porchas · Alejandro Chen Liang · Yeison Cruz Castillo · Aishwarya Ghonge · Aishwarya Saripalli · Thomas SchulzFrontiers in Cardiovascular Medicinedoi 10.3389/fcvm.2026.1926758
ReviewPublished 18 September 2026Microelectrode arrays: from electrophysiology to integrated cancer treatment induced cardiotoxicity assessmentNeda Karami · Sebastian Knafl · Heinz D. Wanzenboeck · Sonia Prado-LópezFrontiers in Electronicsdoi 10.3389/felec.2026.1886715
Original ResearchPublished 18 August 2026Adverse drug events in hospitalized COVID-19 patients: a pharmacovigilance perspective on ICU management and fentanyl exposureMichele Ferreira Murgel · Marcel de Souza Borges Quintana · Roberta Olmo Pinheiro · Vítor Santos da Silva · Cláudia Luciana dos Santos Moura · Vanessa da Gama Oliveira · Cláudia Maria Valete Rosalino · Gilberto Marcelo Sperandio da SilvaFrontiers in Epidemiologydoi 10.3389/fepid.2026.1770145
Original ResearchPublished 12 June 2026Electrophysiological mechanisms behind the differential cardiotoxicity of chemotherapeutic agents Bortezomib and CarfilzomibDario Melgari · Serena Calamaio · Anthony Frosio · Rachele Prevostini · Alessio Malacrida · Luigi Anastasia · Carlo Pappone · Gabriella Nicolini · Guido Cavaletti · Ilaria RivoltaFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1774061
Original ResearchPublished 28 April 2026Sacubitril valsartan combined with bisoprolol reduces doxorubicin-induced cardiotoxicity in rats by attenuating oxidative stressPing Liu · Hui Yang · Runqi Li · Hui Huang · Min XuExperimental Biology and Medicinedoi 10.3389/ebm.2026.10946
Molecular MedicinePublished 6 January 2025Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse modelCaroline Schoenherr · Stefan Pietzsch · Cristina Barca · Franziska E. Müller · Frauke S. Bahr · Martina Kasten · Andre Zeug · Sergej Erschow · Christine S. Falk · Evgeni Ponimaskin · James T. Thackeray · Denise Hilfiker-Kleiner · Melanie Ricke-HochFrontiers in Molecular Medicinedoi 10.3389/fmmed.2024.1487526
